Similar results were also observed in p53-deficient or p53-mutated human pancreatic cancer cells [157], suggesting that siRNA-mediated depletion of RUNX2 promotes the proper DDR regardless of p53 status (Figure 6). The gene discussed is TP53; the disease is pancreatic neoplasm.